Apolipoprotein D (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Apolipoprotein D" in English language version.

refsWebsite

Global rank English rank

77nih.gov

4^th place

55doi.org

2^nd place

21semanticscholar.org

11^th place

8^th place

7harvard.edu

18^th place

17^th place

2ensembl.org

1,626^th place

1,007^th place

1landesbioscience.com

low place

1uqam.ca

8,657^th place

low place

1uow.edu.au

6,834^th place

4,564^th place

doi.org

Drayna DT, McLean JW, Wion KL, Trent JM, Drabkin HA, Lawn RM (June 1987). "Human apolipoprotein D gene: gene sequence, chromosome localization, and homology to the alpha 2u-globulin superfamily". DNA. 6 (3): 199–204. doi:10.1089/dna.1987.6.199. PMID 2439269.
Drayna D, Fielding C, McLean J, Baer B, Castro G, Chen E, et al. (December 1986). "Cloning and expression of human apolipoprotein D cDNA". The Journal of Biological Chemistry. 261 (35): 16535–9. doi:10.1016/S0021-9258(18)66599-8. PMID 3453108.
Muffat J, Walker DW (January 2010). "Apolipoprotein D: an overview of its role in aging and age-related diseases". Cell Cycle. 9 (2): 269–73. doi:10.4161/cc.9.2.10433. PMC 3691099. PMID 20023409.
McConathy WJ, Alaupovic P (February 1976). "Studies on the isolation and partial characterization of apolipoprotein D and lipoprotein D of human plasma". Biochemistry. 15 (3): 515–20. doi:10.1021/bi00648a010. PMID 56198.
Eichinger A, Nasreen A, Kim HJ, Skerra A (October 2007). "Structural insight into the dual ligand specificity and mode of high density lipoprotein association of apolipoprotein D". The Journal of Biological Chemistry. 282 (42): 31068–75. doi:10.1074/jbc.M703552200. PMID 17699160. S2CID 9647650.
Braesch-Andersen S, Beckman L, Paulie S, Kumagai-Braesch M (December 2014). "ApoD mediates binding of HDL to LDL and to growing T24 carcinoma". PLOS ONE. 9 (12): e115180. Bibcode:2014PLoSO...9k5180B. doi:10.1371/journal.pone.0115180. PMC 4267786. PMID 25513803.
Pearlman WH, Guériguian JL, Sawyer ME (August 1973). "A specific progesterone-binding component of human breast cyst fluid". The Journal of Biological Chemistry. 248 (16): 5736–41. doi:10.1016/S0021-9258(19)43566-7. PMID 4723913.
Lea OA (October 1988). "Binding properties of progesterone-binding Cyst protein, PBCP". Steroids. 52 (4): 337–8. doi:10.1016/0039-128x(88)90135-3. PMID 3250014. S2CID 26492300.
Morais Cabral JH, Atkins GL, Sánchez LM, López-Boado YS, López-Otin C, Sawyer L (June 1995). "Arachidonic acid binds to apolipoprotein D: implications for the protein's function". FEBS Letters. 366 (1): 53–6. Bibcode:1995FEBSL.366...53M. doi:10.1016/0014-5793(95)00484-q. PMID 7789516. S2CID 9063157.
Kuehl FA J, Egan RW (28 November 1980). "Prostaglandins, arachidonic acid, and inflammation". Science. 210 (4473): 978–84. Bibcode:1980Sci...210..978K. doi:10.1126/science.6254151. PMID 6254151.
Patel RC, Lange D, McConathy WJ, Patel YC, Patel SC (June 1997). "Probing the structure of the ligand binding cavity of lipocalins by fluorescence spectroscopy". Protein Engineering. 10 (6): 621–5. doi:10.1093/protein/10.6.621. PMID 9278274.
Zeng C, Spielman AI, Vowels BR, Leyden JJ, Biemann K, Preti G (June 1996). "A human axillary odorant is carried by apolipoprotein D". Proceedings of the National Academy of Sciences of the United States of America. 93 (13): 6626–30. Bibcode:1996PNAS...93.6626Z. doi:10.1073/pnas.93.13.6626. PMC 39076. PMID 8692868.
Breustedt DA, Schönfeld DL, Skerra A (February 2006). "Comparative ligand-binding analysis of ten human lipocalins". Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1764 (2): 161–73. doi:10.1016/j.bbapap.2005.12.006. PMID 16461020.
Appari M, Werner R, Wünsch L, Cario G, Demeter J, Hiort O, et al. (June 2009). "Apolipoprotein D (APOD) is a putative biomarker of androgen receptor function in androgen insensitivity syndrome". Journal of Molecular Medicine. 87 (6): 623–32. doi:10.1007/s00109-009-0462-3. PMC 5518750. PMID 19330472.
Lambert J, Provost PR, Marcel YL, Rassart E (20 February 1993). "Structure of the human apolipoprotein D gene promoter region". Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1172 (1–2): 190–2. doi:10.1016/0167-4781(93)90292-l. PMID 7916629.
Do Carmo S, Séguin D, Milne R, Rassart E (15 February 2002). "Modulation of apolipoprotein D and apolipoprotein E mRNA expression by growth arrest and identification of key elements in the promoter". The Journal of Biological Chemistry. 277 (7): 5514–23. doi:10.1074/jbc.M105057200. PMID 11711530. S2CID 45692527.
Do Carmo S, Levros LC J, Rassart E (June 2007). "Modulation of apolipoprotein D expression and translocation under specific stress conditions". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1773 (6): 954–69. doi:10.1016/j.bbamcr.2007.03.007. PMID 17477983.
Vieira AV, Lindstedt K, Schneider WJ, Vieira PM (December 1995). "Identification of a circulatory and oocytic avian apolipoprotein D". Molecular Reproduction and Development. 42 (4): 443–6. doi:10.1002/mrd.1080420411. PMID 8607974. S2CID 34209685.
Ganfornina MD, Sánchez D, Pagano A, Tonachini L, Descalzi-Cancedda F, Martínez S (January 2005). "Molecular characterization and developmental expression pattern of the chicken apolipoprotein D gene: implications for the evolution of vertebrate lipocalins". Developmental Dynamics. 232 (1): 191–9. doi:10.1002/dvdy.20193. PMID 15580625. S2CID 14396229.
Frenette Charron JB, Breton G, Badawi M, Sarhan F (24 April 2002). "Molecular and structural analyses of a novel temperature stress-induced lipocalin from wheat and Arabidopsis". FEBS Letters. 517 (1–3): 129–32. Bibcode:2002FEBSL.517..129F. doi:10.1016/s0014-5793(02)02606-6. PMID 12062422. S2CID 34705682.
Bishop RE, Penfold SS, Frost LS, Höltje JV, Weiner JH (29 September 1995). "Stationary phase expression of a novel Escherichia coli outer membrane lipoprotein and its relationship with mammalian apolipoprotein D. Implications for the origin of lipocalins". The Journal of Biological Chemistry. 270 (39): 23097–103. doi:10.1074/jbc.270.39.23097. PMID 7559452. S2CID 2904679.
Camato R, Marcel YL, Milne RW, Lussier-Cacan S, Weech PK (June 1989). "Protein polymorphism of a human plasma apolipoprotein D antigenic epitope". Journal of Lipid Research. 30 (6): 865–75. doi:10.1016/S0022-2275(20)38304-8. PMID 2477480.
Smith KM, Lawn RM, Wilcox JN (June 1990). "Cellular localization of apolipoprotein D and lecithin:cholesterol acyltransferase mRNA in rhesus monkey tissues by in situ hybridization". Journal of Lipid Research. 31 (6): 995–1004. doi:10.1016/S0022-2275(20)42739-7. PMID 2373967.
Provost PR, Marcel YL, Milne RW, Weech PK, Rassart E (23 September 1991). "Apolipoprotein D transcription occurs specifically in nonproliferating quiescent and senescent fibroblast cultures". FEBS Letters. 290 (1–2): 139–41. Bibcode:1991FEBSL.290..139P. doi:10.1016/0014-5793(91)81244-3. PMID 1915865. S2CID 20185401.
Provost PR, Villeneuve L, Weech PK, Milne RW, Marcel YL, Rassart E (December 1991). "Localization of the major sites of rabbit apolipoprotein D gene transcription by in situ hybridization". Journal of Lipid Research. 32 (12): 1959–70. doi:10.1016/S0022-2275(20)41899-1. PMID 1816324.
Najyb O, Brissette L, Rassart E (26 June 2015). "Apolipoprotein D Internalization Is a Basigin-dependent Mechanism". The Journal of Biological Chemistry. 290 (26): 16077–87. doi:10.1074/jbc.M115.644302. PMC 4481210. PMID 25918162.
Iacono KT, Brown AL, Greene MI, Saouaf SJ (December 2007). "CD147 immunoglobulin superfamily receptor function and role in pathology". Experimental and Molecular Pathology. 83 (3): 283–95. doi:10.1016/j.yexmp.2007.08.014. PMC 2211739. PMID 17945211.
Bodzioch M, Orsó E, Klucken J, Langmann T, Böttcher A, Diederich W, et al. (August 1999). "The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease". Nature Genetics. 22 (4): 347–51. doi:10.1038/11914. PMID 10431237. S2CID 26890624.
Alaupovic P, Schaefer EJ, McConathy WJ, Fesmire JD, Brewer HB J (August 1981). "Plasma apolipoprotein concentrations in familial apolipoprotein A-I and A-II deficiency (Tangier disease)". Metabolism: Clinical and Experimental. 30 (8): 805–9. doi:10.1016/0026-0495(81)90027-5. PMID 6790903.
Albers JJ, Adolphson J, Chen CH, Murayama N, Honma S, Akanuma Y (9 July 1985). "Defective enzyme causes lecithin-cholesterol acyltransferase deficiency in a Japanese kindred". Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 835 (2): 253–7. doi:10.1016/0005-2760(85)90280-2. PMID 4005283.
Baker WA, Hitman GA, Hawrami K, McCarthy MI, Riikonen A, Tuomilehto-Wolf E, et al. (December 1994). "Apolipoprotein D gene polymorphism: a new genetic marker for type 2 diabetic subjects in Nauru and south India". Diabetic Medicine. 11 (10): 947–52. doi:10.1111/j.1464-5491.1994.tb00252.x. PMID 7895459. S2CID 24833816.
Søiland H, Skaland I, Varhaug JE, Kørner H, Janssen EA, Gudlaugsson E, et al. (2009). "Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients". Acta Oncologica. 48 (4): 514–21. doi:10.1080/02841860802620613. PMID 19107621. S2CID 22404040.
Aspinall JO, Bentel JM, Horsfall DJ, Haagensen DE, Marshall VR, Tilley WD (August 1995). "Differential expression of apolipoprotein-D and prostate specific antigen in benign and malignant prostate tissues". The Journal of Urology. 154 (2 Pt 1): 622–8. doi:10.1097/00005392-199508000-00082. PMID 7541868.
Miranda E, Vizoso F, Martín A, Quintela I, Corte MD, Seguí ME, et al. (June 2003). "Apolipoprotein D expression in cutaneous malignant melanoma". Journal of Surgical Oncology. 83 (2): 99–105. doi:10.1002/jso.10245. PMID 12772203. S2CID 25700567.
West RB, Harvell J, Linn SC, Liu CL, Prapong W, Hernandez-Boussard T, et al. (August 2004). "Apo D in soft tissue tumors: a novel marker for dermatofibrosarcoma protuberans". The American Journal of Surgical Pathology. 28 (8): 1063–9. doi:10.1097/01.pas.0000126857.86186.4c. PMID 15252314. S2CID 5773777.
Do Carmo S, Fournier D, Mounier C, Rassart E (April 2009). "Human apolipoprotein D overexpression in transgenic mice induces insulin resistance and alters lipid metabolism". American Journal of Physiology. Endocrinology and Metabolism. 296 (4): E802-11. doi:10.1152/ajpendo.90725.2008. PMID 19176353.
Desmarais F, Bergeron KF, Rassart E, Mounier C (April 2019). "Apolipoprotein D overexpression alters hepatic prostaglandin and omega fatty acid metabolism during the development of a non-inflammatory hepatic steatosis" (PDF). Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1864 (4): 522–531. doi:10.1016/j.bbalip.2019.01.001. PMID 30630053. S2CID 58594626.
Do Carmo S, Forest JC, Giguère Y, Masse A, Lafond J, Rassart E (2 September 2009). "Modulation of Apolipoprotein D levels in human pregnancy and association with gestational weight gain". Reproductive Biology and Endocrinology. 7: 92. doi:10.1186/1477-7827-7-92. PMC 3224896. PMID 19723339.
Martineau C, Najyb O, Signor C, Rassart É, Moreau R (September 2016). "Apolipoprotein D deficiency is associated to high bone turnover, low bone mass and impaired osteoblastic function in aged female mice". Metabolism: Clinical and Experimental. 65 (9): 1247–58. doi:10.1016/j.metabol.2016.05.007. PMC 7094319. PMID 27506732.
Boyles JK, Notterpek LM, Anderson LJ (15 October 1990). "Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I". The Journal of Biological Chemistry. 265 (29): 17805–15. doi:10.1016/S0021-9258(18)38235-8. PMID 2120218.
Boyles JK, Notterpek LM, Wardell MR, Rall SC J (December 1990). "Identification, characterization, and tissue distribution of apolipoprotein D in the rat". Journal of Lipid Research. 31 (12): 2243–56. doi:10.1016/S0022-2275(20)42112-1. PMID 2090718.
Ganfornina MD, Do Carmo S, Martínez E, Tolivia J, Navarro A, Rassart E, et al. (15 August 2010). "ApoD, a glia-derived apolipoprotein, is required for peripheral nerve functional integrity and a timely response to injury". Glia. 58 (11): 1320–34. doi:10.1002/glia.21010. PMC 7165554. PMID 20607718.
Terrisse L, Poirier J, Bertrand P, Merched A, Visvikis S, Siest G, et al. (October 1998). "Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients". Journal of Neurochemistry. 71 (4): 1643–50. doi:10.1046/j.1471-4159.1998.71041643.x. PMID 9751198. S2CID 24675226.
Thomas EA, Dean B, Pavey G, Sutcliffe JG (27 March 2001). "Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders". Proceedings of the National Academy of Sciences of the United States of America. 98 (7): 4066–71. Bibcode:2001PNAS...98.4066T. doi:10.1073/pnas.071056198. PMC 31180. PMID 11274430.
Reindl M, Knipping G, Wicher I, Dilitz E, Egg R, Deisenhammer F, et al. (1 October 2001). "Increased intrathecal production of apolipoprotein D in multiple sclerosis". Journal of Neuroimmunology. 119 (2): 327–32. doi:10.1016/s0165-5728(01)00378-2. PMID 11585636. S2CID 24583456.
Ordoñez C, Navarro A, Perez C, Astudillo A, Martínez E, Tolivia J (April 2006). "Apolipoprotein D expression in substantia nigra of Parkinson disease". Histology and Histopathology. 21 (4): 361–6. doi:10.14670/HH-21.361. PMID 16437381.
Yoshida K, Cleaveland ES, Nagle JW, French S, Yaswen L, Ohshima T, et al. (October 1996). "Molecular cloning of the mouse apolipoprotein D gene and its upregulated expression in Niemann-Pick disease type C mouse model". DNA and Cell Biology. 15 (10): 873–82. doi:10.1089/dna.1996.15.873. PMID 8892759.
Terrisse L, Séguin D, Bertrand P, Poirier J, Milne R, Rassart E (18 June 1999). "Modulation of apolipoprotein D and apolipoprotein E expression in rat hippocampus after entorhinal cortex lesion". Brain Research. Molecular Brain Research. 70 (1): 26–35. doi:10.1016/s0169-328x(99)00123-0. PMID 10381540.
Ong WY, He Y, Suresh S, Patel SC (July 1997). "Differential expression of apolipoprotein D and apolipoprotein E in the kainic acid-lesioned rat hippocampus". Neuroscience. 79 (2): 359–67. doi:10.1016/s0306-4522(96)00608-2. PMID 9200721. S2CID 11857861.
Rickhag M, Wieloch T, Gidö G, Elmér E, Krogh M, Murray J, et al. (January 2006). "Comprehensive regional and temporal gene expression profiling of the rat brain during the first 24 h after experimental stroke identifies dynamic ischemia-induced gene expression patterns, and reveals a biphasic activation of genes in surviving tissue". Journal of Neurochemistry. 96 (1): 14–29. doi:10.1111/j.1471-4159.2005.03508.x. PMID 16300643. S2CID 23231070.
Rickhag M, Deierborg T, Patel S, Ruscher K, Wieloch T (March 2008). "Apolipoprotein D is elevated in oligodendrocytes in the peri-infarct region after experimental stroke: influence of enriched environment". Journal of Cerebral Blood Flow and Metabolism. 28 (3): 551–62. doi:10.1038/sj.jcbfm.9600552. PMID 17851453. S2CID 25611779.
Ganfornina MD, Do Carmo S, Lora JM, Torres-Schumann S, Vogel M, Allhorn M, et al. (August 2008). "Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress". Aging Cell. 7 (4): 506–15. doi:10.1111/j.1474-9726.2008.00395.x. PMC 2574913. PMID 18419796.
Do Carmo S, Jacomy H, Talbot PJ, Rassart E (8 October 2008). "Neuroprotective effect of apolipoprotein D against human coronavirus OC43-induced encephalitis in mice". The Journal of Neuroscience. 28 (41): 10330–8. doi:10.1523/JNEUROSCI.2644-08.2008. PMC 6671015. PMID 18842892.
Najyb O, Do Carmo S, Alikashani A, Rassart E (August 2017). "Apolipoprotein D Overexpression Protects Against Kainate-Induced Neurotoxicity in Mice". Molecular Neurobiology. 54 (6): 3948–3963. doi:10.1007/s12035-016-9920-4. PMC 7091089. PMID 27271124.
Li H, Ruberu K, Muñoz SS, Jenner AM, Spiro A, Zhao H, et al. (May 2015). "Apolipoprotein D modulates amyloid pathology in APP/PS1 Alzheimer's disease mice". Neurobiology of Aging. 36 (5): 1820–33. doi:10.1016/j.neurobiolaging.2015.02.010. PMID 25784209. S2CID 15335129.

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000189058 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000022548 – Ensembl, May 2017

harvard.edu

ui.adsabs.harvard.edu

Braesch-Andersen S, Beckman L, Paulie S, Kumagai-Braesch M (December 2014). "ApoD mediates binding of HDL to LDL and to growing T24 carcinoma". PLOS ONE. 9 (12): e115180. Bibcode:2014PLoSO...9k5180B. doi:10.1371/journal.pone.0115180. PMC 4267786. PMID 25513803.
Morais Cabral JH, Atkins GL, Sánchez LM, López-Boado YS, López-Otin C, Sawyer L (June 1995). "Arachidonic acid binds to apolipoprotein D: implications for the protein's function". FEBS Letters. 366 (1): 53–6. Bibcode:1995FEBSL.366...53M. doi:10.1016/0014-5793(95)00484-q. PMID 7789516. S2CID 9063157.
Kuehl FA J, Egan RW (28 November 1980). "Prostaglandins, arachidonic acid, and inflammation". Science. 210 (4473): 978–84. Bibcode:1980Sci...210..978K. doi:10.1126/science.6254151. PMID 6254151.
Zeng C, Spielman AI, Vowels BR, Leyden JJ, Biemann K, Preti G (June 1996). "A human axillary odorant is carried by apolipoprotein D". Proceedings of the National Academy of Sciences of the United States of America. 93 (13): 6626–30. Bibcode:1996PNAS...93.6626Z. doi:10.1073/pnas.93.13.6626. PMC 39076. PMID 8692868.
Frenette Charron JB, Breton G, Badawi M, Sarhan F (24 April 2002). "Molecular and structural analyses of a novel temperature stress-induced lipocalin from wheat and Arabidopsis". FEBS Letters. 517 (1–3): 129–32. Bibcode:2002FEBSL.517..129F. doi:10.1016/s0014-5793(02)02606-6. PMID 12062422. S2CID 34705682.
Provost PR, Marcel YL, Milne RW, Weech PK, Rassart E (23 September 1991). "Apolipoprotein D transcription occurs specifically in nonproliferating quiescent and senescent fibroblast cultures". FEBS Letters. 290 (1–2): 139–41. Bibcode:1991FEBSL.290..139P. doi:10.1016/0014-5793(91)81244-3. PMID 1915865. S2CID 20185401.
Thomas EA, Dean B, Pavey G, Sutcliffe JG (27 March 2001). "Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders". Proceedings of the National Academy of Sciences of the United States of America. 98 (7): 4066–71. Bibcode:2001PNAS...98.4066T. doi:10.1073/pnas.071056198. PMC 31180. PMID 11274430.

landesbioscience.com

Muffat J, Walker DW (January 2010). "Apolipoprotein D: an overview of its role in aging and age-related diseases". Cell Cycle. 9 (2): 269–73. doi:10.4161/cc.9.2.10433. PMC 3691099. PMID 20023409.

nih.gov

pubmed.ncbi.nlm.nih.gov

Drayna DT, McLean JW, Wion KL, Trent JM, Drabkin HA, Lawn RM (June 1987). "Human apolipoprotein D gene: gene sequence, chromosome localization, and homology to the alpha 2u-globulin superfamily". DNA. 6 (3): 199–204. doi:10.1089/dna.1987.6.199. PMID 2439269.
Drayna D, Fielding C, McLean J, Baer B, Castro G, Chen E, et al. (December 1986). "Cloning and expression of human apolipoprotein D cDNA". The Journal of Biological Chemistry. 261 (35): 16535–9. doi:10.1016/S0021-9258(18)66599-8. PMID 3453108.
Muffat J, Walker DW (January 2010). "Apolipoprotein D: an overview of its role in aging and age-related diseases". Cell Cycle. 9 (2): 269–73. doi:10.4161/cc.9.2.10433. PMC 3691099. PMID 20023409.
Ayrault Jarrier M, Levy G, Polonovski J (August 1963). "[Study of Human Serum Alpha-Lipoproteins by Immunoelectrophoresis]". Bulletin de la Société de Chimie Biologique. 45: 703–13. PMID 14051455.
McConathy WJ, Alaupovic P (February 1976). "Studies on the isolation and partial characterization of apolipoprotein D and lipoprotein D of human plasma". Biochemistry. 15 (3): 515–20. doi:10.1021/bi00648a010. PMID 56198.
Peitsch MC, Boguski MS (February 1990). "Is apolipoprotein D a mammalian bilin-binding protein?". The New Biologist. 2 (2): 197–206. PMID 2083249.
Eichinger A, Nasreen A, Kim HJ, Skerra A (October 2007). "Structural insight into the dual ligand specificity and mode of high density lipoprotein association of apolipoprotein D". The Journal of Biological Chemistry. 282 (42): 31068–75. doi:10.1074/jbc.M703552200. PMID 17699160. S2CID 9647650.
Braesch-Andersen S, Beckman L, Paulie S, Kumagai-Braesch M (December 2014). "ApoD mediates binding of HDL to LDL and to growing T24 carcinoma". PLOS ONE. 9 (12): e115180. Bibcode:2014PLoSO...9k5180B. doi:10.1371/journal.pone.0115180. PMC 4267786. PMID 25513803.
Pearlman WH, Guériguian JL, Sawyer ME (August 1973). "A specific progesterone-binding component of human breast cyst fluid". The Journal of Biological Chemistry. 248 (16): 5736–41. doi:10.1016/S0021-9258(19)43566-7. PMID 4723913.
Lea OA (October 1988). "Binding properties of progesterone-binding Cyst protein, PBCP". Steroids. 52 (4): 337–8. doi:10.1016/0039-128x(88)90135-3. PMID 3250014. S2CID 26492300.
Morais Cabral JH, Atkins GL, Sánchez LM, López-Boado YS, López-Otin C, Sawyer L (June 1995). "Arachidonic acid binds to apolipoprotein D: implications for the protein's function". FEBS Letters. 366 (1): 53–6. Bibcode:1995FEBSL.366...53M. doi:10.1016/0014-5793(95)00484-q. PMID 7789516. S2CID 9063157.
Kuehl FA J, Egan RW (28 November 1980). "Prostaglandins, arachidonic acid, and inflammation". Science. 210 (4473): 978–84. Bibcode:1980Sci...210..978K. doi:10.1126/science.6254151. PMID 6254151.
Patel RC, Lange D, McConathy WJ, Patel YC, Patel SC (June 1997). "Probing the structure of the ligand binding cavity of lipocalins by fluorescence spectroscopy". Protein Engineering. 10 (6): 621–5. doi:10.1093/protein/10.6.621. PMID 9278274.
Zeng C, Spielman AI, Vowels BR, Leyden JJ, Biemann K, Preti G (June 1996). "A human axillary odorant is carried by apolipoprotein D". Proceedings of the National Academy of Sciences of the United States of America. 93 (13): 6626–30. Bibcode:1996PNAS...93.6626Z. doi:10.1073/pnas.93.13.6626. PMC 39076. PMID 8692868.
Breustedt DA, Schönfeld DL, Skerra A (February 2006). "Comparative ligand-binding analysis of ten human lipocalins". Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1764 (2): 161–73. doi:10.1016/j.bbapap.2005.12.006. PMID 16461020.
Appari M, Werner R, Wünsch L, Cario G, Demeter J, Hiort O, et al. (June 2009). "Apolipoprotein D (APOD) is a putative biomarker of androgen receptor function in androgen insensitivity syndrome". Journal of Molecular Medicine. 87 (6): 623–32. doi:10.1007/s00109-009-0462-3. PMC 5518750. PMID 19330472.
Lambert J, Provost PR, Marcel YL, Rassart E (20 February 1993). "Structure of the human apolipoprotein D gene promoter region". Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1172 (1–2): 190–2. doi:10.1016/0167-4781(93)90292-l. PMID 7916629.
Do Carmo S, Séguin D, Milne R, Rassart E (15 February 2002). "Modulation of apolipoprotein D and apolipoprotein E mRNA expression by growth arrest and identification of key elements in the promoter". The Journal of Biological Chemistry. 277 (7): 5514–23. doi:10.1074/jbc.M105057200. PMID 11711530. S2CID 45692527.
Do Carmo S, Levros LC J, Rassart E (June 2007). "Modulation of apolipoprotein D expression and translocation under specific stress conditions". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1773 (6): 954–69. doi:10.1016/j.bbamcr.2007.03.007. PMID 17477983.
Vieira AV, Lindstedt K, Schneider WJ, Vieira PM (December 1995). "Identification of a circulatory and oocytic avian apolipoprotein D". Molecular Reproduction and Development. 42 (4): 443–6. doi:10.1002/mrd.1080420411. PMID 8607974. S2CID 34209685.
Ganfornina MD, Sánchez D, Pagano A, Tonachini L, Descalzi-Cancedda F, Martínez S (January 2005). "Molecular characterization and developmental expression pattern of the chicken apolipoprotein D gene: implications for the evolution of vertebrate lipocalins". Developmental Dynamics. 232 (1): 191–9. doi:10.1002/dvdy.20193. PMID 15580625. S2CID 14396229.
Sánchez D, Ganfornina MD, Torres-Schumann S, Speese SD, Lora JM, Bastiani MJ (June 2000). "Characterization of two novel lipocalins expressed in the Drosophila embryonic nervous system". The International Journal of Developmental Biology. 44 (4): 349–59. PMID 10949044.
Frenette Charron JB, Breton G, Badawi M, Sarhan F (24 April 2002). "Molecular and structural analyses of a novel temperature stress-induced lipocalin from wheat and Arabidopsis". FEBS Letters. 517 (1–3): 129–32. Bibcode:2002FEBSL.517..129F. doi:10.1016/s0014-5793(02)02606-6. PMID 12062422. S2CID 34705682.
Bishop RE, Penfold SS, Frost LS, Höltje JV, Weiner JH (29 September 1995). "Stationary phase expression of a novel Escherichia coli outer membrane lipoprotein and its relationship with mammalian apolipoprotein D. Implications for the origin of lipocalins". The Journal of Biological Chemistry. 270 (39): 23097–103. doi:10.1074/jbc.270.39.23097. PMID 7559452. S2CID 2904679.
Camato R, Marcel YL, Milne RW, Lussier-Cacan S, Weech PK (June 1989). "Protein polymorphism of a human plasma apolipoprotein D antigenic epitope". Journal of Lipid Research. 30 (6): 865–75. doi:10.1016/S0022-2275(20)38304-8. PMID 2477480.
Smith KM, Lawn RM, Wilcox JN (June 1990). "Cellular localization of apolipoprotein D and lecithin:cholesterol acyltransferase mRNA in rhesus monkey tissues by in situ hybridization". Journal of Lipid Research. 31 (6): 995–1004. doi:10.1016/S0022-2275(20)42739-7. PMID 2373967.
Provost PR, Marcel YL, Milne RW, Weech PK, Rassart E (23 September 1991). "Apolipoprotein D transcription occurs specifically in nonproliferating quiescent and senescent fibroblast cultures". FEBS Letters. 290 (1–2): 139–41. Bibcode:1991FEBSL.290..139P. doi:10.1016/0014-5793(91)81244-3. PMID 1915865. S2CID 20185401.
Provost PR, Villeneuve L, Weech PK, Milne RW, Marcel YL, Rassart E (December 1991). "Localization of the major sites of rabbit apolipoprotein D gene transcription by in situ hybridization". Journal of Lipid Research. 32 (12): 1959–70. doi:10.1016/S0022-2275(20)41899-1. PMID 1816324.
Najyb O, Brissette L, Rassart E (26 June 2015). "Apolipoprotein D Internalization Is a Basigin-dependent Mechanism". The Journal of Biological Chemistry. 290 (26): 16077–87. doi:10.1074/jbc.M115.644302. PMC 4481210. PMID 25918162.
Iacono KT, Brown AL, Greene MI, Saouaf SJ (December 2007). "CD147 immunoglobulin superfamily receptor function and role in pathology". Experimental and Molecular Pathology. 83 (3): 283–95. doi:10.1016/j.yexmp.2007.08.014. PMC 2211739. PMID 17945211.
Bodzioch M, Orsó E, Klucken J, Langmann T, Böttcher A, Diederich W, et al. (August 1999). "The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease". Nature Genetics. 22 (4): 347–51. doi:10.1038/11914. PMID 10431237. S2CID 26890624.
Alaupovic P, Schaefer EJ, McConathy WJ, Fesmire JD, Brewer HB J (August 1981). "Plasma apolipoprotein concentrations in familial apolipoprotein A-I and A-II deficiency (Tangier disease)". Metabolism: Clinical and Experimental. 30 (8): 805–9. doi:10.1016/0026-0495(81)90027-5. PMID 6790903.
Albers JJ, Adolphson J, Chen CH, Murayama N, Honma S, Akanuma Y (9 July 1985). "Defective enzyme causes lecithin-cholesterol acyltransferase deficiency in a Japanese kindred". Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 835 (2): 253–7. doi:10.1016/0005-2760(85)90280-2. PMID 4005283.
Baker WA, Hitman GA, Hawrami K, McCarthy MI, Riikonen A, Tuomilehto-Wolf E, et al. (December 1994). "Apolipoprotein D gene polymorphism: a new genetic marker for type 2 diabetic subjects in Nauru and south India". Diabetic Medicine. 11 (10): 947–52. doi:10.1111/j.1464-5491.1994.tb00252.x. PMID 7895459. S2CID 24833816.
Ryu B, Jones J, Hollingsworth MA, Hruban RH, Kern SE (1 March 2001). "Invasion-specific genes in malignancy: serial analysis of gene expression comparisons of primary and passaged cancers". Cancer Research. 61 (5): 1833–8. PMID 11280733.
Díez-Itza I, Vizoso F, Merino AM, Sánchez LM, Tolivia J, Fernández J, et al. (February 1994). "Expression and prognostic significance of apolipoprotein D in breast cancer". The American Journal of Pathology. 144 (2): 310–20. PMC 1887137. PMID 8311115.
Søiland H, Skaland I, Varhaug JE, Kørner H, Janssen EA, Gudlaugsson E, et al. (2009). "Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients". Acta Oncologica. 48 (4): 514–21. doi:10.1080/02841860802620613. PMID 19107621. S2CID 22404040.
Aspinall JO, Bentel JM, Horsfall DJ, Haagensen DE, Marshall VR, Tilley WD (August 1995). "Differential expression of apolipoprotein-D and prostate specific antigen in benign and malignant prostate tissues". The Journal of Urology. 154 (2 Pt 1): 622–8. doi:10.1097/00005392-199508000-00082. PMID 7541868.
Miranda E, Vizoso F, Martín A, Quintela I, Corte MD, Seguí ME, et al. (June 2003). "Apolipoprotein D expression in cutaneous malignant melanoma". Journal of Surgical Oncology. 83 (2): 99–105. doi:10.1002/jso.10245. PMID 12772203. S2CID 25700567.
West RB, Harvell J, Linn SC, Liu CL, Prapong W, Hernandez-Boussard T, et al. (August 2004). "Apo D in soft tissue tumors: a novel marker for dermatofibrosarcoma protuberans". The American Journal of Surgical Pathology. 28 (8): 1063–9. doi:10.1097/01.pas.0000126857.86186.4c. PMID 15252314. S2CID 5773777.
Do Carmo S, Fournier D, Mounier C, Rassart E (April 2009). "Human apolipoprotein D overexpression in transgenic mice induces insulin resistance and alters lipid metabolism". American Journal of Physiology. Endocrinology and Metabolism. 296 (4): E802-11. doi:10.1152/ajpendo.90725.2008. PMID 19176353.
Desmarais F, Bergeron KF, Rassart E, Mounier C (April 2019). "Apolipoprotein D overexpression alters hepatic prostaglandin and omega fatty acid metabolism during the development of a non-inflammatory hepatic steatosis" (PDF). Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1864 (4): 522–531. doi:10.1016/j.bbalip.2019.01.001. PMID 30630053. S2CID 58594626.
Do Carmo S, Forest JC, Giguère Y, Masse A, Lafond J, Rassart E (2 September 2009). "Modulation of Apolipoprotein D levels in human pregnancy and association with gestational weight gain". Reproductive Biology and Endocrinology. 7: 92. doi:10.1186/1477-7827-7-92. PMC 3224896. PMID 19723339.
Martineau C, Najyb O, Signor C, Rassart É, Moreau R (September 2016). "Apolipoprotein D deficiency is associated to high bone turnover, low bone mass and impaired osteoblastic function in aged female mice". Metabolism: Clinical and Experimental. 65 (9): 1247–58. doi:10.1016/j.metabol.2016.05.007. PMC 7094319. PMID 27506732.
Boyles JK, Notterpek LM, Anderson LJ (15 October 1990). "Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I". The Journal of Biological Chemistry. 265 (29): 17805–15. doi:10.1016/S0021-9258(18)38235-8. PMID 2120218.
Boyles JK, Notterpek LM, Wardell MR, Rall SC J (December 1990). "Identification, characterization, and tissue distribution of apolipoprotein D in the rat". Journal of Lipid Research. 31 (12): 2243–56. doi:10.1016/S0022-2275(20)42112-1. PMID 2090718.
Ganfornina MD, Do Carmo S, Martínez E, Tolivia J, Navarro A, Rassart E, et al. (15 August 2010). "ApoD, a glia-derived apolipoprotein, is required for peripheral nerve functional integrity and a timely response to injury". Glia. 58 (11): 1320–34. doi:10.1002/glia.21010. PMC 7165554. PMID 20607718.
Terrisse L, Poirier J, Bertrand P, Merched A, Visvikis S, Siest G, et al. (October 1998). "Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients". Journal of Neurochemistry. 71 (4): 1643–50. doi:10.1046/j.1471-4159.1998.71041643.x. PMID 9751198. S2CID 24675226.
Thomas EA, Dean B, Pavey G, Sutcliffe JG (27 March 2001). "Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders". Proceedings of the National Academy of Sciences of the United States of America. 98 (7): 4066–71. Bibcode:2001PNAS...98.4066T. doi:10.1073/pnas.071056198. PMC 31180. PMID 11274430.
Reindl M, Knipping G, Wicher I, Dilitz E, Egg R, Deisenhammer F, et al. (1 October 2001). "Increased intrathecal production of apolipoprotein D in multiple sclerosis". Journal of Neuroimmunology. 119 (2): 327–32. doi:10.1016/s0165-5728(01)00378-2. PMID 11585636. S2CID 24583456.
Ordoñez C, Navarro A, Perez C, Astudillo A, Martínez E, Tolivia J (April 2006). "Apolipoprotein D expression in substantia nigra of Parkinson disease". Histology and Histopathology. 21 (4): 361–6. doi:10.14670/HH-21.361. PMID 16437381.
Yoshida K, Cleaveland ES, Nagle JW, French S, Yaswen L, Ohshima T, et al. (October 1996). "Molecular cloning of the mouse apolipoprotein D gene and its upregulated expression in Niemann-Pick disease type C mouse model". DNA and Cell Biology. 15 (10): 873–82. doi:10.1089/dna.1996.15.873. PMID 8892759.
Terrisse L, Séguin D, Bertrand P, Poirier J, Milne R, Rassart E (18 June 1999). "Modulation of apolipoprotein D and apolipoprotein E expression in rat hippocampus after entorhinal cortex lesion". Brain Research. Molecular Brain Research. 70 (1): 26–35. doi:10.1016/s0169-328x(99)00123-0. PMID 10381540.
Ong WY, He Y, Suresh S, Patel SC (July 1997). "Differential expression of apolipoprotein D and apolipoprotein E in the kainic acid-lesioned rat hippocampus". Neuroscience. 79 (2): 359–67. doi:10.1016/s0306-4522(96)00608-2. PMID 9200721. S2CID 11857861.
Rickhag M, Wieloch T, Gidö G, Elmér E, Krogh M, Murray J, et al. (January 2006). "Comprehensive regional and temporal gene expression profiling of the rat brain during the first 24 h after experimental stroke identifies dynamic ischemia-induced gene expression patterns, and reveals a biphasic activation of genes in surviving tissue". Journal of Neurochemistry. 96 (1): 14–29. doi:10.1111/j.1471-4159.2005.03508.x. PMID 16300643. S2CID 23231070.
Rickhag M, Deierborg T, Patel S, Ruscher K, Wieloch T (March 2008). "Apolipoprotein D is elevated in oligodendrocytes in the peri-infarct region after experimental stroke: influence of enriched environment". Journal of Cerebral Blood Flow and Metabolism. 28 (3): 551–62. doi:10.1038/sj.jcbfm.9600552. PMID 17851453. S2CID 25611779.
Ganfornina MD, Do Carmo S, Lora JM, Torres-Schumann S, Vogel M, Allhorn M, et al. (August 2008). "Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress". Aging Cell. 7 (4): 506–15. doi:10.1111/j.1474-9726.2008.00395.x. PMC 2574913. PMID 18419796.
Do Carmo S, Jacomy H, Talbot PJ, Rassart E (8 October 2008). "Neuroprotective effect of apolipoprotein D against human coronavirus OC43-induced encephalitis in mice". The Journal of Neuroscience. 28 (41): 10330–8. doi:10.1523/JNEUROSCI.2644-08.2008. PMC 6671015. PMID 18842892.
Najyb O, Do Carmo S, Alikashani A, Rassart E (August 2017). "Apolipoprotein D Overexpression Protects Against Kainate-Induced Neurotoxicity in Mice". Molecular Neurobiology. 54 (6): 3948–3963. doi:10.1007/s12035-016-9920-4. PMC 7091089. PMID 27271124.
Li H, Ruberu K, Muñoz SS, Jenner AM, Spiro A, Zhao H, et al. (May 2015). "Apolipoprotein D modulates amyloid pathology in APP/PS1 Alzheimer's disease mice". Neurobiology of Aging. 36 (5): 1820–33. doi:10.1016/j.neurobiolaging.2015.02.010. PMID 25784209. S2CID 15335129.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Entrez Gene: APOD apolipoprotein D".
Muffat J, Walker DW (January 2010). "Apolipoprotein D: an overview of its role in aging and age-related diseases". Cell Cycle. 9 (2): 269–73. doi:10.4161/cc.9.2.10433. PMC 3691099. PMID 20023409.
Braesch-Andersen S, Beckman L, Paulie S, Kumagai-Braesch M (December 2014). "ApoD mediates binding of HDL to LDL and to growing T24 carcinoma". PLOS ONE. 9 (12): e115180. Bibcode:2014PLoSO...9k5180B. doi:10.1371/journal.pone.0115180. PMC 4267786. PMID 25513803.
Zeng C, Spielman AI, Vowels BR, Leyden JJ, Biemann K, Preti G (June 1996). "A human axillary odorant is carried by apolipoprotein D". Proceedings of the National Academy of Sciences of the United States of America. 93 (13): 6626–30. Bibcode:1996PNAS...93.6626Z. doi:10.1073/pnas.93.13.6626. PMC 39076. PMID 8692868.
Appari M, Werner R, Wünsch L, Cario G, Demeter J, Hiort O, et al. (June 2009). "Apolipoprotein D (APOD) is a putative biomarker of androgen receptor function in androgen insensitivity syndrome". Journal of Molecular Medicine. 87 (6): 623–32. doi:10.1007/s00109-009-0462-3. PMC 5518750. PMID 19330472.
Najyb O, Brissette L, Rassart E (26 June 2015). "Apolipoprotein D Internalization Is a Basigin-dependent Mechanism". The Journal of Biological Chemistry. 290 (26): 16077–87. doi:10.1074/jbc.M115.644302. PMC 4481210. PMID 25918162.
Iacono KT, Brown AL, Greene MI, Saouaf SJ (December 2007). "CD147 immunoglobulin superfamily receptor function and role in pathology". Experimental and Molecular Pathology. 83 (3): 283–95. doi:10.1016/j.yexmp.2007.08.014. PMC 2211739. PMID 17945211.
Díez-Itza I, Vizoso F, Merino AM, Sánchez LM, Tolivia J, Fernández J, et al. (February 1994). "Expression and prognostic significance of apolipoprotein D in breast cancer". The American Journal of Pathology. 144 (2): 310–20. PMC 1887137. PMID 8311115.
Do Carmo S, Forest JC, Giguère Y, Masse A, Lafond J, Rassart E (2 September 2009). "Modulation of Apolipoprotein D levels in human pregnancy and association with gestational weight gain". Reproductive Biology and Endocrinology. 7: 92. doi:10.1186/1477-7827-7-92. PMC 3224896. PMID 19723339.
Martineau C, Najyb O, Signor C, Rassart É, Moreau R (September 2016). "Apolipoprotein D deficiency is associated to high bone turnover, low bone mass and impaired osteoblastic function in aged female mice". Metabolism: Clinical and Experimental. 65 (9): 1247–58. doi:10.1016/j.metabol.2016.05.007. PMC 7094319. PMID 27506732.
Ganfornina MD, Do Carmo S, Martínez E, Tolivia J, Navarro A, Rassart E, et al. (15 August 2010). "ApoD, a glia-derived apolipoprotein, is required for peripheral nerve functional integrity and a timely response to injury". Glia. 58 (11): 1320–34. doi:10.1002/glia.21010. PMC 7165554. PMID 20607718.
Thomas EA, Dean B, Pavey G, Sutcliffe JG (27 March 2001). "Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders". Proceedings of the National Academy of Sciences of the United States of America. 98 (7): 4066–71. Bibcode:2001PNAS...98.4066T. doi:10.1073/pnas.071056198. PMC 31180. PMID 11274430.
Ganfornina MD, Do Carmo S, Lora JM, Torres-Schumann S, Vogel M, Allhorn M, et al. (August 2008). "Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress". Aging Cell. 7 (4): 506–15. doi:10.1111/j.1474-9726.2008.00395.x. PMC 2574913. PMID 18419796.
Do Carmo S, Jacomy H, Talbot PJ, Rassart E (8 October 2008). "Neuroprotective effect of apolipoprotein D against human coronavirus OC43-induced encephalitis in mice". The Journal of Neuroscience. 28 (41): 10330–8. doi:10.1523/JNEUROSCI.2644-08.2008. PMC 6671015. PMID 18842892.
Najyb O, Do Carmo S, Alikashani A, Rassart E (August 2017). "Apolipoprotein D Overexpression Protects Against Kainate-Induced Neurotoxicity in Mice". Molecular Neurobiology. 54 (6): 3948–3963. doi:10.1007/s12035-016-9920-4. PMC 7091089. PMID 27271124.

semanticscholar.org

api.semanticscholar.org

Eichinger A, Nasreen A, Kim HJ, Skerra A (October 2007). "Structural insight into the dual ligand specificity and mode of high density lipoprotein association of apolipoprotein D". The Journal of Biological Chemistry. 282 (42): 31068–75. doi:10.1074/jbc.M703552200. PMID 17699160. S2CID 9647650.
Lea OA (October 1988). "Binding properties of progesterone-binding Cyst protein, PBCP". Steroids. 52 (4): 337–8. doi:10.1016/0039-128x(88)90135-3. PMID 3250014. S2CID 26492300.
Morais Cabral JH, Atkins GL, Sánchez LM, López-Boado YS, López-Otin C, Sawyer L (June 1995). "Arachidonic acid binds to apolipoprotein D: implications for the protein's function". FEBS Letters. 366 (1): 53–6. Bibcode:1995FEBSL.366...53M. doi:10.1016/0014-5793(95)00484-q. PMID 7789516. S2CID 9063157.
Do Carmo S, Séguin D, Milne R, Rassart E (15 February 2002). "Modulation of apolipoprotein D and apolipoprotein E mRNA expression by growth arrest and identification of key elements in the promoter". The Journal of Biological Chemistry. 277 (7): 5514–23. doi:10.1074/jbc.M105057200. PMID 11711530. S2CID 45692527.
Vieira AV, Lindstedt K, Schneider WJ, Vieira PM (December 1995). "Identification of a circulatory and oocytic avian apolipoprotein D". Molecular Reproduction and Development. 42 (4): 443–6. doi:10.1002/mrd.1080420411. PMID 8607974. S2CID 34209685.
Ganfornina MD, Sánchez D, Pagano A, Tonachini L, Descalzi-Cancedda F, Martínez S (January 2005). "Molecular characterization and developmental expression pattern of the chicken apolipoprotein D gene: implications for the evolution of vertebrate lipocalins". Developmental Dynamics. 232 (1): 191–9. doi:10.1002/dvdy.20193. PMID 15580625. S2CID 14396229.
Frenette Charron JB, Breton G, Badawi M, Sarhan F (24 April 2002). "Molecular and structural analyses of a novel temperature stress-induced lipocalin from wheat and Arabidopsis". FEBS Letters. 517 (1–3): 129–32. Bibcode:2002FEBSL.517..129F. doi:10.1016/s0014-5793(02)02606-6. PMID 12062422. S2CID 34705682.
Bishop RE, Penfold SS, Frost LS, Höltje JV, Weiner JH (29 September 1995). "Stationary phase expression of a novel Escherichia coli outer membrane lipoprotein and its relationship with mammalian apolipoprotein D. Implications for the origin of lipocalins". The Journal of Biological Chemistry. 270 (39): 23097–103. doi:10.1074/jbc.270.39.23097. PMID 7559452. S2CID 2904679.
Provost PR, Marcel YL, Milne RW, Weech PK, Rassart E (23 September 1991). "Apolipoprotein D transcription occurs specifically in nonproliferating quiescent and senescent fibroblast cultures". FEBS Letters. 290 (1–2): 139–41. Bibcode:1991FEBSL.290..139P. doi:10.1016/0014-5793(91)81244-3. PMID 1915865. S2CID 20185401.
Bodzioch M, Orsó E, Klucken J, Langmann T, Böttcher A, Diederich W, et al. (August 1999). "The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease". Nature Genetics. 22 (4): 347–51. doi:10.1038/11914. PMID 10431237. S2CID 26890624.
Baker WA, Hitman GA, Hawrami K, McCarthy MI, Riikonen A, Tuomilehto-Wolf E, et al. (December 1994). "Apolipoprotein D gene polymorphism: a new genetic marker for type 2 diabetic subjects in Nauru and south India". Diabetic Medicine. 11 (10): 947–52. doi:10.1111/j.1464-5491.1994.tb00252.x. PMID 7895459. S2CID 24833816.
Søiland H, Skaland I, Varhaug JE, Kørner H, Janssen EA, Gudlaugsson E, et al. (2009). "Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients". Acta Oncologica. 48 (4): 514–21. doi:10.1080/02841860802620613. PMID 19107621. S2CID 22404040.
Miranda E, Vizoso F, Martín A, Quintela I, Corte MD, Seguí ME, et al. (June 2003). "Apolipoprotein D expression in cutaneous malignant melanoma". Journal of Surgical Oncology. 83 (2): 99–105. doi:10.1002/jso.10245. PMID 12772203. S2CID 25700567.
West RB, Harvell J, Linn SC, Liu CL, Prapong W, Hernandez-Boussard T, et al. (August 2004). "Apo D in soft tissue tumors: a novel marker for dermatofibrosarcoma protuberans". The American Journal of Surgical Pathology. 28 (8): 1063–9. doi:10.1097/01.pas.0000126857.86186.4c. PMID 15252314. S2CID 5773777.
Desmarais F, Bergeron KF, Rassart E, Mounier C (April 2019). "Apolipoprotein D overexpression alters hepatic prostaglandin and omega fatty acid metabolism during the development of a non-inflammatory hepatic steatosis" (PDF). Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1864 (4): 522–531. doi:10.1016/j.bbalip.2019.01.001. PMID 30630053. S2CID 58594626.
Terrisse L, Poirier J, Bertrand P, Merched A, Visvikis S, Siest G, et al. (October 1998). "Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients". Journal of Neurochemistry. 71 (4): 1643–50. doi:10.1046/j.1471-4159.1998.71041643.x. PMID 9751198. S2CID 24675226.
Reindl M, Knipping G, Wicher I, Dilitz E, Egg R, Deisenhammer F, et al. (1 October 2001). "Increased intrathecal production of apolipoprotein D in multiple sclerosis". Journal of Neuroimmunology. 119 (2): 327–32. doi:10.1016/s0165-5728(01)00378-2. PMID 11585636. S2CID 24583456.
Ong WY, He Y, Suresh S, Patel SC (July 1997). "Differential expression of apolipoprotein D and apolipoprotein E in the kainic acid-lesioned rat hippocampus". Neuroscience. 79 (2): 359–67. doi:10.1016/s0306-4522(96)00608-2. PMID 9200721. S2CID 11857861.
Rickhag M, Wieloch T, Gidö G, Elmér E, Krogh M, Murray J, et al. (January 2006). "Comprehensive regional and temporal gene expression profiling of the rat brain during the first 24 h after experimental stroke identifies dynamic ischemia-induced gene expression patterns, and reveals a biphasic activation of genes in surviving tissue". Journal of Neurochemistry. 96 (1): 14–29. doi:10.1111/j.1471-4159.2005.03508.x. PMID 16300643. S2CID 23231070.
Rickhag M, Deierborg T, Patel S, Ruscher K, Wieloch T (March 2008). "Apolipoprotein D is elevated in oligodendrocytes in the peri-infarct region after experimental stroke: influence of enriched environment". Journal of Cerebral Blood Flow and Metabolism. 28 (3): 551–62. doi:10.1038/sj.jcbfm.9600552. PMID 17851453. S2CID 25611779.
Li H, Ruberu K, Muñoz SS, Jenner AM, Spiro A, Zhao H, et al. (May 2015). "Apolipoprotein D modulates amyloid pathology in APP/PS1 Alzheimer's disease mice". Neurobiology of Aging. 36 (5): 1820–33. doi:10.1016/j.neurobiolaging.2015.02.010. PMID 25784209. S2CID 15335129.

uow.edu.au

ro.uow.edu.au

Li H, Ruberu K, Muñoz SS, Jenner AM, Spiro A, Zhao H, et al. (May 2015). "Apolipoprotein D modulates amyloid pathology in APP/PS1 Alzheimer's disease mice". Neurobiology of Aging. 36 (5): 1820–33. doi:10.1016/j.neurobiolaging.2015.02.010. PMID 25784209. S2CID 15335129.

uqam.ca

archipel.uqam.ca

Desmarais F, Bergeron KF, Rassart E, Mounier C (April 2019). "Apolipoprotein D overexpression alters hepatic prostaglandin and omega fatty acid metabolism during the development of a non-inflammatory hepatic steatosis" (PDF). Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1864 (4): 522–531. doi:10.1016/j.bbalip.2019.01.001. PMID 30630053. S2CID 58594626.